arBtrage CAPITALIZING MARKETS checking… Sign in

Forte Biosciences, Inc.

FBRX Health Care Biotechnology: Pharmaceutical Preparations
$16.52
▼ -1.0% Today
as of Jun 7, 07:14 ET
Last 30 days -37.39% Apr 28 → Jun 05
$15.56 $19.04 $22.52 $25.99 $29.47 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$16.37
High
$16.70
Low
$15.71
Volume
$408,168
Avg Vol
$175,680
Mkt Cap
$425M
P/E (TTM)
Beta
52w High
$35.80
52w Low
$9.10
Div Yield
Shares Out
$14M

Overview

52-week range
$9.10
$36
28% of range
Avg surprise (last 1)
-53.9%
Avg reaction (last 2)
+5.6%
100% positive
Latest IV / EM
273%
EM ±37.8% · $18 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-6.78$-5.19$-3.60$-2.01$-0.42 Actual $-0.42Actual $-6.57Actual $-4.03Actual $-6.78Actual $-4.54Actual $-1.37Est $-0.89Actual $-0.96Actual $-0.99Actual $-1.24 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-22M$-19M$-15M$-12M$-9M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-1.24 +9.5% +8.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.99 financials
Mon Jun 30, 2025Jun 2025 $-0.96 financials
Thu May 15, 2025Mar/2025 $-1.37 $-0.89 -53.9% +3.0% earnings
Mon Sep 30, 2024Sep 2024 $-4.54 financials
Sun Jun 30, 2024Jun 2024 $-6.78 financials
Sun Mar 31, 2024Mar 2024 $-4.03 financials
Sat Sep 30, 2023Sep 2023 $-6.57 financials
Fri Jun 30, 2023Jun 2023 $-0.42 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-22M$-18M$-12M$-16M$-9M$-13M
Net income$-22M$-18M$-11M$-16M$-8M$-13M
EPS (diluted)$-1.24$-0.99$-0.96$-1.37$-4.54$-6.78

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$58M$77M$93M$106M$46M$22M$16M$24M
Inventory
Total current assets$65M$81M$95M$108M$47M$61M$18M$26M
Total assets$67M$83M$97M$108M$47M$62M$18M$26M
Long-term debt
Total liabilities$25M$22M
Total equity$42M$61M$84M$99M$38M$52M$9M$17M

Implied volatility — last 90 days

268%270%273%275%278% Jun 07 — IV 273% · EM ±37.8%

Sector peers